Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi

Lisa B Haddad; Caryl Feldacker; Denise J Jamieson; Hannock Tweya; Carrie Cwiak; Amy G Bryant; Mina C Hosseinipour; Thomas Chaweza; Linly Mlundira; Fanny Kachale; Gretchen S Stuart; Irving Hoffman; Sam Phiri

doi:10.1016/j.ijgo.2014.03.026

Back

Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi

Journal article

Peer reviewed

Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi

Lisa B Haddad, Caryl Feldacker, Denise J Jamieson, Hannock Tweya, Carrie Cwiak, Amy G Bryant, Mina C Hosseinipour, Thomas Chaweza, Linly Mlundira, Fanny Kachale, …

International journal of gynecology and obstetrics, Vol.126(3), pp.213-216

09/2014

DOI: 10.1016/j.ijgo.2014.03.026

PMCID: PMC4149777

PMID: 24890746

Files and links (1)

url

https://www.ncbi.nlm.nih.gov/pmc/articles/4149777View

Open Access

Abstract

To determine medical eligibility for contraceptive use, contraceptive preference, and acceptance of a copper intrauterine device (IUD) among a cohort of HIV-infected women receiving antiretroviral therapy (ART). All HIV-infected women who received ART and sought contraceptive services at the Lighthouse clinic, an integrated HIV/ART clinic in Lilongwe, Malawi, between August and December 2010 were invited to participate in a structured interview. Eligibility and preference for the following contraceptive methods were assessed: combined hormonal contraceptives, progestogen-only pills, copper IUD, injectable depot medroxyprogesterone acetate (DMPA), and contraceptive implants. The final sample included 281 women; five were pregnant. The remaining 276 women were eligible for at least three contraceptive methods, with 242 (87.7%) eligible for all five methods evaluated. After counseling, 163 (58.0%) selected DMPA and 98 (34.9%) selected an IUD as their preferred contraceptive method. Regardless of their method of choice, 222 (79.0%) women agreed to have an IUD placed on the same day. Most methods of contraception are safe for use by HIV-infected women. Approximately 80% of the women were willing to receive an IUD. Efforts must be made to increase education about, and access to, long-acting reversible methods that may be acceptable and appropriate contraceptive options for HIV-infected women.

Adolescent

Adult

Anti-HIV Agents - administration & dosage

Choice Behavior

Contraception Behavior

Eligibility Determination

Female

HIV Infections - drug therapy

Humans

Intrauterine Devices, Copper

Malawi

Patient Acceptance of Health Care

Details

Title: Subtitle: Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi
Creators: Lisa B Haddad - Emory University
Caryl Feldacker - Office of the National Coordinator for Health Information Technology
Denise J Jamieson - Emory University
Hannock Tweya - Lighthouse Trust
Carrie Cwiak - Emory University
Amy G Bryant - University of North Carolina at Chapel Hill
Mina C Hosseinipour - University of North Carolina at Chapel Hill
Thomas Chaweza - Lighthouse Trust
Linly Mlundira - Lighthouse Trust
Fanny Kachale - Ministry of Health
Gretchen S Stuart - University of North Carolina at Chapel Hill
Irving Hoffman - University of North Carolina at Chapel Hill
Sam Phiri - Lighthouse Trust
Resource Type: Journal article
Publication Details: International journal of gynecology and obstetrics, Vol.126(3), pp.213-216
DOI: 10.1016/j.ijgo.2014.03.026
PMID: 24890746
PMCID: PMC4149777
NLM abbreviation: Int J Gynaecol Obstet
ISSN: 0020-7292
eISSN: 1879-3479
Grant note: K23 HD078153 / NICHD NIH HHS P30 AI050410 / NIAID NIH HHS P30 AI050409 / NIAID NIH HHS
Language: English
Date published: 09/2014
Academic Unit: Obstetrics and Gynecology; VPMA - Administration
Record Identifier: 9984446452002771

Metrics

8 Record Views

10 Times Cited - Web of Science